AMOREPACIFIC VENTURES
AMOREPACIFIC Ventures is the AMOREPACIFIC group’s corporate venture capital arm. They invest in early and later stage opportunities which are strategically relevant to AMOREPACIFIC.
AMOREPACIFIC VENTURES
Founded:
1945-01-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
SSL By Default LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network Font Awesome Domain Not Resolving Wordpress Plugins Global Site Tag Organization Schema
Similar Organizations
Alumni Ventures
Alumni Ventures Group provides diversified venture portfolios to individual investors who previously haven't had access to VC.
Venrock
Venrock is a venture capital firm investing in technology and healthcare companies.
Current Employees Featured
Tim Kim
Tim Kim Chief Investment Principal @ AMOREPACIFIC Ventures Chief Investment Principal
Mike Kim
Mike Kim Investment Principal @ AMOREPACIFIC Ventures Investment Principal
Paul Kang
Paul Kang Founder & Managing Director @ AMOREPACIFIC Ventures Founder & Managing Director
Founder
Paul Kang
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2019-12-17 | MILK Makeup | AMOREPACIFIC Ventures investment in Venture Round - MILK Makeup | N/A |
2018-06-01 | BlockOdyssey | AMOREPACIFIC Ventures investment in Seed Round - BlockOdyssey | N/A |
2016-01-07 | Elastagen | AMOREPACIFIC Ventures investment in Series B - Elastagen | 13 M AUD |
2015-11-13 | WayWearable | AMOREPACIFIC Ventures investment in Venture Round - WayWearable | 2 B KRW |
2013-07-09 | TRIA Beauty | AMOREPACIFIC Ventures investment in Private Equity Round - TRIA Beauty | 45.5 M USD |
2013-02-26 | Brickell Biotech | AMOREPACIFIC Ventures investment in Series B - Brickell Biotech | 7 M USD |
2012-12-19 | Neothetics | AMOREPACIFIC Ventures investment in Series C - Neothetics | 20.6 M USD |
2012-12-19 | Obalon Therapeutics | AMOREPACIFIC Ventures investment in Venture Round - Obalon Therapeutics | 5 M USD |
2012-12-19 | Evofem Biosciences | AMOREPACIFIC Ventures investment in Series C - Evofem Biosciences | 20.6 M USD |